Daniel DeNeui is a distinguished leader and entrepreneur with a proven track record in strategic planning, business development, and leadership coaching. His expertise in human behavior and psychology and exceptional public speaking skills have enabled him to successfully establish and grow several multi-million dollar enterprises from the ground up, using bootstrap capital.
Currently, as the Chief Executive Officer of EVEXIAS Health Solutions®, Daniel is pioneering advancements in medical wellness. His leadership revitalizes the healthcare sector by enhancing the work experience for practitioners and improving patient care through innovative approaches.
Working alongside his spouse, Daniel directs the strategic vision for the EVEXIAS-FarmaKeio organization, aiming to transform healthcare by expanding educational, therapeutic, and business solutions. Since he assumed leadership in 2015, his extensive science and business management background has been critical in evolving the company's product offerings, including developing the EvexiPEL® Method, PeptideSolutions™, and NutraceuticalSolutions™.
Daniel is deeply committed to formulating personalized wellness plans at EVEXIAS that incorporate an integrative and functional approach to health. These plans tackle the underlying causes of health issues, focusing mainly on hormone imbalances. The organization utilizes state-of-the-art treatments such as bioidentical hormone replacement therapy and sophisticated nutraceuticals to tailor treatments to each patient's needs.
Under his leadership, EVEXIAS has also made significant strides in incorporating technology to enhance educational and clinical practices. In 2022, Daniel launched EVEXIAS Online, a platform that enriches the academic landscape for healthcare professionals by facilitating discussions, sharing case studies, and providing access to a wealth of research and resources. In early 2023, he led the organization’s most extensive training event focused on hormone therapy, significantly enhancing the practical skills of healthcare providers.
Before his current tenure at EVEXIAS, Daniel held influential positions at Asperio Labs and BioTE Medical, where he concentrated on hormone optimization and healthy aging initiatives. His career also includes impactful leadership roles at Independent Producers of America and Cornerstone America, where he was instrumental in developing strategic sales and product expansions.
Daniel DeNeui's academic background in organic chemistry from Clemson University has provided a solid foundation for his diverse professional achievements. Beyond his business accomplishments, he is committed to philanthropy, supporting charities, and assisting families during challenging times.